Skip to main content

Advertisement

SpringerLink
Log in

Intravitreal bevacizumab for CNV-complicated tilted disk syndrome

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Tilted disc syndrome is a congenital anomaly characterized by an inferonasal “tilting” of the optic disc. We report three patients affected by macular neovascularisation-complicated tilted disk syndrome treated by intravitreal bevacizumab.

Methods

Three interventional case reports are hereby documented. Ophthalmic evaluations were registered, including monthly visual acuity examination, OCT and fluorescein angiography before and after consecutive intravitreal injection of 1.25 mg bevacizumab (0.05 ml, Avastin).

Results

All patients, aged more than 65 years, experienced decreased visual acuity after an observation period of 6 (two patients) and 3 months (one patient). Angiographic leakage with neuroretinal rarefaction and RPE/choriocapillary complex elevation at OCT remained persistent in two patients and reduced in one.

Conclusions

No benefit in terms of visual acuity was noted after intravitreal bevacizumab treatments. Larger studies should be conducted to confirm our small series observation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Apple DJ, Rabb MF, Walsh PM (1982) Congenital anomalies of the optic disc. Surv Ophthalmol 27(1):3–41. doi:10.1016/0039-6257(82)90111-4

    Article  PubMed  CAS  Google Scholar 

  2. Dorrell D (1978) The tilted disc. Br J Ophthalmol 62(1):16–20. doi:10.1136/bjo.62.1.16

    Article  PubMed  CAS  Google Scholar 

  3. Vongphanit J, Mitchell P, Wang JJ (2002) Population prevalence of tilted optic disks and the relationship of this sign to refractive error. Am J Ophthalmol 133(5):679–685. doi:10.1016/S0002-9394(02)01339-9

    Article  PubMed  Google Scholar 

  4. Cohen SY, Quentel G, Guiberteau B, Delahaye-Mazza C, Gaudric A (1998) Macular serous retinal detachment caused by subretinal leakage in tilted disc syndrome. Ophthalmology 105(10):1831–1834. doi:10.1016/S0161-6420(98)91024-7

    Article  PubMed  CAS  Google Scholar 

  5. Stur M (1988) Congenital tilted disk syndrome associated with parafoveal subretinal neovascularization. Am J Ophthalmol 105(1):98–99

    PubMed  CAS  Google Scholar 

  6. Prost M, De Laey JJ (1988) Choroidal neovascularization in tilted disc syndrome. Int Ophthalmol 12(2):131–135. doi:10.1007/BF00137139

    Article  PubMed  CAS  Google Scholar 

  7. Nakanishi H, Tsujikawa A, Gotoh N, Hayashi H, Iwama D, Tamura H, Otani A, Yoshimura N (2008) Macular complications on the border of an inferior staphyloma associated with tilted disk syndrome. Retina 28(10):1493–1501. doi:10.1097/IAE.0b013e318183589c

    Article  PubMed  Google Scholar 

  8. Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O, Roca G (2008) Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. Br J Ophthalmol 92(8):1035–1039. doi:10.1136/bjo.2007.130260

    Article  PubMed  CAS  Google Scholar 

  9. Chan WM, Lai TY, Liu DT, Lam DS (2007) Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Ophthalmology 114(12):2190–2196. doi:10.1016/j.ophtha.2007.03.043

    Article  PubMed  Google Scholar 

  10. Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB (2009) Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. Am J Ophthalmol 147(1):84–93

    Article  PubMed  CAS  Google Scholar 

  11. Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y (2009) Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol 147(1):94–100

    Article  PubMed  CAS  Google Scholar 

  12. Pece A, Isola V, Vadalà M, Matranga D (2006) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study. Retina 26(7):746–751. doi:10.1097/01.iae.0000244256.60524.c0

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ospedale Fatebenefratelli-Oftalmico, Corso di Porta Nuova 23, 20100, Milano, Italy

    Paolo Milani, Giuseppe Moretti, Pruneri Lino & Antonio Scialdone

  2. Ospedale Vizzolo Predabissi, Strada Pandina 1, Vizzolo Predabissi, Melegnano, Milano, Italy

    Alfredo Pece

Authors
  1. Paolo Milani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfredo Pece
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pruneri Lino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonio Scialdone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Milani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milani, P., Pece, A., Moretti, G. et al. Intravitreal bevacizumab for CNV-complicated tilted disk syndrome. Graefes Arch Clin Exp Ophthalmol 247, 1179–1182 (2009). https://doi.org/10.1007/s00417-009-1096-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-009-1096-4

Keywords

Search

Navigation